Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Prof Jérémie Calais presents a talk on FAP-targeted PET imaging in cancer patients.
He begins by explaining the biology behind the FAP (fibroblast activation protein) target and why it has garnered attention.
Dr Calais goes on to look at case examples of FAP-targeted PET imaging before looking at comparisons with FDG PET, considered the standard of care for many cancers.
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Breast and emerging indications for IORT